The cornea is the clear, outermost layer of the eye. Its outer border, the limbus, contains a large volume of healthy stem ...
Converting one type of cell to another—for example, a skin cell to a neuron—can be done through a process that requires the ...
Eye injuries that damage the cornea are usually irreversible and cause blindness. But a new clinical trial has repaired this ...
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study. The discovery could lead ...
4don MSN
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce ...
Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in ... How Healthy Stem Cells Turn Into Or ...
4d
News-Medical.Net on MSNScientists discover key molecular switch for blood stem cell regenerationA single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell ...
6d
Live Science on MSN'In that moment, that was everything to me': Patient describes joy of regaining vision in 1 eye after new stem cell therapyA first-of-its-kind stem cell transplant has changed the life of a man who was left blind in one eye following a firework ...
A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...
2don MSN
An international group of researchers has identified an important mechanism that enables stem cells to evade immune rejection ...
Stem cell therapies are a type of cell therapy in which the cells used are either stem cells (as in the case of bone marrow transplantation) or are derived from stem cells, as is this case with ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results